<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>RSS for Matteo Tomei</title><link>http://academic.research.microsoft.com/Rss.aspx?id=55988365</link><description>Search RSS feed for Microsoft Academic Search</description><generator>MSRA Libra RSS Burner</generator><copyright>(c)2008 Microsoft Corpration, All right reserved.</copyright><pubDate>Wed, 19 Jun 2013 01:31:08 GMT</pubDate><lastBuildDate>Wed, 19 Jun 2013 01:31:08 GMT</lastBuildDate><category /><item><title>Matteo Tomei (Personal Info)
      </title><link>http://academic.research.microsoft.com/Author/55988365</link><pubDate>Wed, 19 Jun 2013 01:31:08 GMT</pubDate><description><![CDATA[<p /><p>
          Publications: 1</p><p>
          Citation Count: 1</p><p>
          G-index: 1</p><p>
         Field Rating: 1</p><p>Fields of study: <a href="http://academic.research.microsoft.com/RankList?entitytype=2&topDomainID=6&subDomainID=7&last=0&start=1&end=100">Diseases</a><span class="span-break" >,&nbsp;</span><a href="http://academic.research.microsoft.com/RankList?entitytype=2&topDomainID=6&subDomainID=12&last=0&start=1&end=100">Immunology</a><br/></p><p>Homepage:
        <a href="" /></p><p>
          Permanent Link:
          <a href="http://academic.research.microsoft.com/Author/55988365">http://academic.research.microsoft.com/Author/55988365</a></p>]]></description><guid isPermaLink="false">5598836711</guid></item><item><title>Structural organization of NadAΔ 351–405, a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level</title><link>http://academic.research.microsoft.com/Publication/35495513</link><pubDate>Wed, 19 Jun 2013 01:31:08 GMT</pubDate><guid isPermaLink="false">5598836535495513</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/23617997'>Claudia Magagnoli</a>,  <a href='http://academic.research.microsoft.com/Author/27874808'>Angela Bardotti</a>,  <a href='http://academic.research.microsoft.com/Author/27880286'>Giuseppe De Conciliis</a>,  <a href='http://academic.research.microsoft.com/Author/27880287'>Rosy Galasso</a>,  <a href='http://academic.research.microsoft.com/Author/55988365'>Matteo Tomei</a>,  <a href='http://academic.research.microsoft.com/Author/4475848'>Cristiana Campa</a>,  <a href='http://academic.research.microsoft.com/Author/26267115'>Carlo Pennatini</a>,  <a href='http://academic.research.microsoft.com/Author/27880289'>Maruska Cerchioni</a>,  <a href='http://academic.research.microsoft.com/Author/27874980'>Barbara Fabbri</a>,  <a href='http://academic.research.microsoft.com/Author/53633451'>Sara Giannini</a>,  <a href='http://academic.research.microsoft.com/Author/55988366'>Giovanni L. Mattioli</a>,  <a href='http://academic.research.microsoft.com/Author/23772776'>Alessia Biolchi</a>,  <a href='http://academic.research.microsoft.com/Author/27695997'>Sandro D’Ascenzi</a>,  <a href='http://academic.research.microsoft.com/Author/26079044'>Friedhelm Helling</a></dl><p></p><p>Vaccine, vol. 27, no. 15, pp. 2156-2170, 2009</p><p>(Citations:1)</p>]]></description></item></channel></rss>